Patents by Inventor Judith Aronhime

Judith Aronhime has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of pregabalin
    Patent number: 7417165
    Abstract: Crystalline form of Pregabalin characterized by X-ray powder diffraction peaks at about 5.8, 18.4, 19.2, 20.7, and 23.7° 2?±0.2° 2?, methods for its preparation, its pharmaceutical compositions thereof, and methods for the preparation of crystalline form of Pregabalin characterized by X-ray powder diffraction peaks at about 5.7, 15.4, 17.2, 18.2, and 23.0° 2?±0.2° 2?, are provided.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: August 26, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Judith Aronhime, Sigalit Levi, Lilach Hedvati
  • Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
    Publication number: 20080200532
    Abstract: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
    Type: Application
    Filed: April 23, 2008
    Publication date: August 21, 2008
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman
  • Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
    Patent number: 7414140
    Abstract: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: August 19, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman, Sharon Avhar-Maydan
  • CARVEDILOL
    Publication number: 20080194838
    Abstract: This invention relates to an improved process of preparing carvedilol, as well as a new crystalline hydrate and solvate and forms of carvedilol, processes for the manufacture thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: April 15, 2008
    Publication date: August 14, 2008
    Applicants: Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.
    Inventors: Jean Hildesheim, Sergey Finogueev, Judith Aronhime, Ben-Zion Dolitzky, Shoshana Ben-Valid, Ilan Kor
  • Polymorphic form of atorvastatin calcium
    Patent number: 7411075
    Abstract: The present invention relates to atorvastatin calcium, a useful agent for lowering serum cholesterol levels. New atorvastatin calcium Form V, processes for preparing the new form, and pharmaceutical compositions and dosage forms containing the new form are disclosed.
    Type: Grant
    Filed: November 16, 2000
    Date of Patent: August 12, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Ari Ayalon, Michal Levinger, Sofia Roytblat, Valerie Niddam, Revital Lifshitz, Judith Aronhime
  • Sertraline hydrochloride polymorphs
    Publication number: 20080176949
    Abstract: The present invention is directed to forms II, III, V, VI, VII, VIII, IX and X of sertraline hydrochloride and novel methods for their preparation. According to the present invention, sertraline hydrochloride polymorph II may be produced by slurrying sertraline hydrochloride polymorph VI in aprotic organic solvent. Sertraline hydrochloride polymorphic form III may be produced by heating sertraline hydrochloride polymorphs V and VI. Sertraline hydrochloride forms V and VI may be produced from either sertraline hydrochloride or sertraline base by crystallization. Sertraline hydrochloride Form VII may be produced by suspending sertraline chloride polymorph V in water, followed by filtration. Sertraline hydrochloride Forms VIII and IX may be produced by suspending sertraline base in water followed by acidification and filtration. Sertraline hydrochloride Form X may be produced by suspending sertraline hydrochloride in benzyl alcohol with heating, followed by filtration.
    Type: Application
    Filed: March 21, 2008
    Publication date: July 24, 2008
    Inventors: Eduard Schwartz, Tamar Nidam, Anita Liberman, Marioara Mendelovici, Judith Aronhime, Claude Singer, Evgeni Valdman
  • Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
    Publication number: 20080167498
    Abstract: The present invention relates to novel essentially pure venlafaxine and the process of preparation thereof. The present invention also relates to novel solvate forms of venlafaxine hydrochloride and the process of preparation thereof. Furthermore, the present invention provides a novel process for preparing venlafaxine hydrochloride from venlafaxine; the process comprises the steps of: i) preparing a mixture of venlafaxine with acetone; and ii) exposing the mixture in gaseous hydrochloric acid.
    Type: Application
    Filed: March 13, 2008
    Publication date: July 10, 2008
    Inventors: Ben-Zion Dolitzky, Judith Aronhime, Shlomit Wizel, Gennady A. Nisnevich
  • Processes for preparation of polymorphic form II of sertraline hydrochloride
    Publication number: 20080161607
    Abstract: Provided are processes for preparation of crystalline sertraline hydrochloride Form II substantially free of other polymorphic forms of sertraline hydrochloride, preferably on an industrial scale.
    Type: Application
    Filed: March 5, 2008
    Publication date: July 3, 2008
    Inventors: Ronen Borochovitch, Marioara Mendelovici, Tamar Nidam, Ruth Tenengauzer, Julia Hrakovsky, Judith Aronhime
  • Crystal forms of lamotrigine and processes for their preparations
    Patent number: 7390807
    Abstract: The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.
    Type: Grant
    Filed: January 31, 2005
    Date of Patent: June 24, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Nissim Garti, Yana Berkovich, Ben-Zion Dolitzky, Judith Aronhime, Claude Singer, Anita Liebermann, Neomi Gershon
  • Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
    Publication number: 20080146817
    Abstract: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
    Type: Application
    Filed: January 29, 2007
    Publication date: June 19, 2008
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman, Sharon Avhar-Maydan
  • Crystal forms of lamotrigine and processes for their preparations
    Publication number: 20080139808
    Abstract: The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.
    Type: Application
    Filed: January 30, 2008
    Publication date: June 12, 2008
    Inventors: Nissim Garti, Yana Berkovich, Ben-Zion Dolitzky, Judith Aronhime, Claude Singer, Anita Liebermann, Neomi Gershon
  • Carvedilol phosphate
    Publication number: 20080125476
    Abstract: The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel amorphous and crystalline forms. Also disclosed are pharmaceutical compositions comprising the novel amorphous and crystalline forms and uses thereof.
    Type: Application
    Filed: June 28, 2007
    Publication date: May 29, 2008
    Inventors: Santiago Ini, Sigalit Levi, Michal Rafilovich, Judith Aronhime, Mili Abramov, Ron Bar-Shavit, Eran Turgeman
  • Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
    Patent number: 7368468
    Abstract: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: May 6, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman
  • Processes for preparation of crystalline mycophenolate sodium
    Publication number: 20080103317
    Abstract: Provided are crystalline mycophenolate sodium forms and processes for their preparation.
    Type: Application
    Filed: December 14, 2007
    Publication date: May 1, 2008
    Inventors: Sandor Molnar, Csaba Szabo, Tivadar Tamas, Janos Hajko, Adrienne Kovacsne-Mezei, Judith Aronhime
  • Processes for preparation of crystalline mycophenolate sodium
    Publication number: 20080097096
    Abstract: Provided are crystalline mycophenolate sodium forms and processes for their preparation.
    Type: Application
    Filed: December 14, 2007
    Publication date: April 24, 2008
    Inventors: Sandor Molnar, Csaba Szabo, Tivadar Tamas, Janos Hajko, Adrienne Kovacsne-Mezei, Judith Aronhime
  • Polymorphic form B2 of Ziprasidone base
    Publication number: 20080091019
    Abstract: Provided is a crystalline form of ziprasidone base and processes for its preparation.
    Type: Application
    Filed: December 4, 2007
    Publication date: April 17, 2008
    Inventors: Judith Aronhime, Marioara Mendelovici, Tamas Koltai, Rinat Moshkovits-Kaptsan, Tamar Nidam
  • Polymorphic form B2 of ziprasidone base
    Publication number: 20080091018
    Abstract: Provided is a crystalline form of ziprasidone base and processes for its preparation.
    Type: Application
    Filed: December 4, 2007
    Publication date: April 17, 2008
    Inventors: Judith Aronhime, Marioara Mendelovici, Tamas Koltai, Rinat Moshkovits-Kaptsan, Tamar Nidam
  • Tigecycline crystalline forms and processes for preparation thereof
    Publication number: 20080090789
    Abstract: The present invention relates to solid crystalline Tigecycline, and crystalline forms thereof.
    Type: Application
    Filed: April 24, 2007
    Publication date: April 17, 2008
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Tsiperman, Sigalit Levi, Judith Aronhime, Tamas Koltai
  • Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form alpha
    Publication number: 20080090833
    Abstract: Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described.
    Type: Application
    Filed: April 27, 2007
    Publication date: April 17, 2008
    Inventors: Alexandr Jegorov, Miloslav Chudik, Judith Aronhime, Ales Gavenda, Jiri Faustmann
  • Polymorphic form B2 of ziprasidone base
    Publication number: 20080091017
    Abstract: Provided is a crystalline form of ziprasidone base and processes for its preparation.
    Type: Application
    Filed: December 4, 2007
    Publication date: April 17, 2008
    Inventors: Judith Aronhime, Marioara Mendelovici, Tamas Koltai, Rinat Moshkovits-Kaptsan, Tamar Nidam